Conclusions
TNBC
Working on pretreatment tissue samples of TNBC derived from a prospective randomized clinical trial addressing the role of carboplatin added to standard anthracycline/taxane therapy, we established individual gene alterations and gene signatures that correlated with pCR, OS, and DFS. These biomarkers warrant further clinical investigation.